Effects of Acute and Chronic Empagliflozin Heart Failure

NCT05553938 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Empagliflozin 10 mg
DRUG: Placebo

Sponsor

Yale University